PDL1 expression by immunohistochemistry (IHC) is employed for stratification in other tumor types such as non-small cell lung cancer (NSCLC); however, it is not routinely used as a predictive biomarker for CRC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.